These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 6281592)
21. An evaluation of two years of clinical experience with ketoconazole. Symoens J; Moens M; Dom J; Scheijgrond H; Dony J; Schuermans V; Legendre R; Finestine N Rev Infect Dis; 1980; 2(4):674-87. PubMed ID: 6255549 [No Abstract] [Full Text] [Related]
26. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489 [TBL] [Abstract][Full Text] [Related]
27. [Peculiarities in the treatment of systemic mycoses]. Del Negro G AMB Rev Assoc Med Bras; 1985; 31(3-4):47-51. PubMed ID: 3878542 [No Abstract] [Full Text] [Related]
28. Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. Drouhet E; Dupont B Am J Med; 1983 Jan; 74(1B):30-47. PubMed ID: 6295150 [TBL] [Abstract][Full Text] [Related]
30. Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis. Negroni R; Robles AM; Arechavala A; Tuculet MA; Galimberti R Rev Infect Dis; 1980; 2(4):643-9. PubMed ID: 6255544 [TBL] [Abstract][Full Text] [Related]
31. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections. Meunier-Carpentier F Am J Med; 1984 Apr; 76(4):652-6. PubMed ID: 6324589 [TBL] [Abstract][Full Text] [Related]
32. Ketoconazole. Hay R Br Med J (Clin Res Ed); 1982 Aug 28-Sep 4; 285(6342):584-5. PubMed ID: 6297655 [No Abstract] [Full Text] [Related]
33. Treatment of systemic mycoses. Abernathy RS Medicine (Baltimore); 1973 Sep; 52(5):385-94. PubMed ID: 4725961 [No Abstract] [Full Text] [Related]
34. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Hann IM; Prentice HG; Corringham R; Blacklock HA; Keaney M; Shannon M; Noone P; Gascoigne E; Fox J; Boesen E; Szawatkowski M; Hoffbrand AV Lancet; 1982 Apr; 1(8276):826-9. PubMed ID: 6122057 [TBL] [Abstract][Full Text] [Related]
35. Therapy of endogenous fungal endophthalmitis: miconazole or amphotericin B for coccidioidal and candidal infection. Blumenkranz MS; Stevens DA Arch Ophthalmol; 1980 Jul; 98(7):1216-20. PubMed ID: 6967308 [TBL] [Abstract][Full Text] [Related]
36. Strategies in the treatment of systemic fungal infections. Medoff G; Kobayashi GS N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703 [No Abstract] [Full Text] [Related]
37. Oral antifungal agent effective even for widespread infections. Check WA JAMA; 1980 Nov; 244(18):2019-20. PubMed ID: 6253688 [No Abstract] [Full Text] [Related]